With the help of virus research technology, we have a deeper understanding of how plaque accumulates in the brains of Alzheimer's disease patients. Weird viral proteins can cause a series of degenerative brain diseases. This discovery may help solve the mystery of Alzheimer's research. This is why this disease can kill patients within a few years. However, this usually leads to a slow recession that lasts for decades. Using the tools used to study the viral protein prp, the researchers discovered changes in the shape of the protein associated with Alzheimer's disease. This will affect the degree of damage to the brain.
At the 2015 Prion Conference in Fort Collins, Colorado, USA from May 26th to 29th, neuroscientist Larry Walker explained how he used Al virus research methods to analyze Alzheimer's disease. .. Different β-amyloid strains in the brains of patients with the disease. Differences between these different strains may lead to differences in disease symptoms and progression. Walker of Emory University in Georgia said: "The Alzheimer's field is not paying close attention to the development of the ing virus field."
At this meeting, Walker introduced a case study of a patient with Alzheimer's disease. During an autopsy after the patient died, the researchers unexpectedly discovered that his brain was covered with beta amyloid plaques. Surprisingly, these plaques are not sensitive to the diagnostic imaging molecules commonly used to detect them. Walker used a luminescent compound to isolate compound virus proteins and found that the patient’s protein aggregates had abnormal structures. In the face of diagnostic technology, this makes you an "invisible person". Other research groups are using nuclear magnetic resonance technology to gather evidence of beta-amyloid or virus test results to see if there are different strains of tau.
"I have written a lot of talk articles before, thinking that the virus model is useful, but now I am doing more serious work." Colorado State University, one of the organizers of the conference, said Glentling, a university virus researcher.